The study and its comparison
Three hundred people with gingivitis were randomized to a toothpaste containing an ascorbic-acid derivative or a control toothpaste. The primary endpoint was the gingival index at three months. [1]
The intention-to-treat comparison was not significant. The per-protocol analysis favored the derivative, and selected redness, bleeding and salivary antioxidant measures also improved. [1]
What the finding establishes
A favorable adherent-participant analysis should not replace the main randomized analysis. The preparation was applied as toothpaste, so this does not establish an oral vitamin dose for gum disease. Funding and conflicts were not established from the abstract. A laboratory antioxidant measure is not the same as preventing tooth loss. [1]
A hypothetical distinction
Imagine a result appears only after restricting analysis to protocol completers. That restriction can change the interpretation of randomization.
| Detail | Interpretation |
|---|---|
| Measured outcome | Keep the endpoint specific |
| Study preparation | Not every retail product |
| Remaining uncertainty | Not resolved by a mechanism |
Sources for this article
- Effects of an ascorbic acid-derivative dentifrice in patients with gingivitis: a double-masked, randomized, controlled clinical trial.
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.